RecruitingPhase 3NCT06430801
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Sponsor: Merck Sharp & Dohme LLC
Clive, IA · +86 more sites
3 recruiting crohn's disease studies with a site in Clive, IA.
Sponsor: Merck Sharp & Dohme LLC
Clive, IA · +86 more sites
Sponsor: Janssen Research & Development, LLC
Clive, IA · +38 more sites
Sponsor: Sanofi
Clive, IA · Waterloo, IA · +123 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.